Intelligent Medicine Acquisition Corp. Class A Common Stock
IQMD
IQMD was delisted on the 26th of April, 2023.
58 hedge funds and large institutions have $156M invested in Intelligent Medicine Acquisition Corp. Class A Common Stock in 2022 Q2 according to their latest regulatory filings, with 7 funds opening new positions, 15 increasing their positions, 8 reducing their positions, and 6 closing their positions.
88% more repeat investments, than reductions
Existing positions increased: 15 | Existing positions reduced: 8
17% more first-time investments, than exits
New positions opened: 7 | Existing positions closed: 6
10.23% more ownership
Funds ownership: 65.15% → 75.39% (+10%)
2% more funds holding
Funds holding: 57 → 58 (+1)
4% more capital invested
Capital invested by funds: $151M → $156M (+$5.34M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
HSBC Holdings
London,
United Kingdom
|
+$6.55M |
| 2 |
SCM
Saba Capital Management
New York
|
+$6.01M |
| 3 |
FTCM
First Trust Capital Management
Chicago,
Illinois
|
+$3.2M |
| 4 |
D.E. Shaw & Co
New York
|
+$2.75M |
| 5 |
Millennium Management
New York
|
+$2.64M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
LA
Linden Advisors
New York
|
-$6.55M |
| 2 |
Citadel Advisors
Miami,
Florida
|
-$6M |
| 3 |
BCM
Beryl Capital Management
Redondo Beach,
California
|
-$5.65M |
| 4 |
MI
MMCAP International
Grand Cayman,
Cayman Islands
|
-$5M |
| 5 |
SC
Sculptor Capital
New York
|
-$1.42M |
IQMD Hedge Fund Activity: Q2 2022 in Review
58 of the 5,960 institutional investors tracked by Wall St. Rank reported a position in Intelligent Medicine Acquisition Corp. Class A Common Stock (IQMD) for Q2 2022, worth a combined $156M — up 3.5% from $151M a quarter earlier.
Buyers outnumbered sellers: 7 funds opened new IQMD positions and 6 closed out — a net gain of 1 holder — while 15 added to existing stakes and 8 trimmed.
The largest buyer was HSBC Holdings, opening a new position worth an estimated $6.55M. The largest seller was Linden Advisors, cutting an estimated $6.55M.
- 58 institutional investors held Intelligent Medicine Acquisition Corp. Class A Common Stock (IQMD) as of Q2 2022, up from 57 in Q1 2022.
- Funds reported $156M of Intelligent Medicine Acquisition Corp. Class A Common Stock stock for Q2 2022, up 3.5% quarter-over-quarter.
- 7 funds opened new Intelligent Medicine Acquisition Corp. Class A Common Stock positions in Q2 2022 and 6 closed out, a net change of +1 holder.
- The largest Intelligent Medicine Acquisition Corp. Class A Common Stock buyer in Q2 2022 was HSBC Holdings, an estimated $6.55M added.
- The largest Intelligent Medicine Acquisition Corp. Class A Common Stock seller in Q2 2022 was Linden Advisors, an estimated $6.55M sold.
Based on aggregated 13F filings for Q2 2022.